Synthesis and characterization of anti-EGFR fluorescent nanoparticles for optical molecular imaging

Bioconjugate Chemistry

Volumn 24, Issue 2, 2013, Pages 167-175

  Chan, Leslie W ^a   Wang, Yak Nam ^b   Lin, Lih Y ^c   Upton, Melissa P ^d   Hwang, Joo Ha ^d   Pun, Suzie H ^a  

^a University of Washington   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c University of Washington   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; CYTOLOGY; FLUORESCENCE; MOLECULAR IMAGING; NANOPARTICLES; POLYSTYRENES; SYNTHESIS (CHEMICAL);

ANTI-EGFR; CELLULAR MARKERS; EARLY CANCER; FLUORESCENT NANOPARTICLES; MOLECULAR MARKER; OPTICAL MOLECULAR IMAGING; POLYSTYRENE PARTICLE; REGIONS OF INTEREST; SYNTHESIS AND CHARACTERIZATIONS; SYNTHESISED;

ANTIBODIES;

ENHANCED GREEN FLUORESCENT PROTEIN; FUNCTIONAL GROUP; MACROGOL; MALEIMIDE; NANOPARTICLE; POLYSTYRENE;

ADSORPTION; ARTICLE; CONJUGATION; CONTROLLED STUDY; CYTOTOXICITY; ENCAPSULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR IMAGING; PROTEIN EXPRESSION; PROTEIN TARGETING; SYNTHESIS;

EID: 84874073320     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc300355y     Document Type: Article

References (46)

1. Pohl, H. and Welch, H. G. (2005) The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence J. Natl. Cancer Inst. 97, 142-6
2. Cameron, A. J., Ott, B. J., and Payne, W. S. (1985) The incidence of adenocarcinoma in columnar-lined (Barretts) esophagus New England Journal of Medicine 313, 857-859
3. Wetscher, G. J., Hinder, R. A., Bagchi, D., Hinder, P. R., Bagchi, M., Perdikis, G., and McGinn, T. (1995) Reflux esophagitis in humans is mediated by oxygen-derived free radicals Am. J. Surg. 170, 552-6 discussion 556-7
4. Olyaee, M., Sontag, S., Salman, W., Schnell, T., Mobarhan, S., Eiznhamer, D., and Keshavarzian, A. (1995) Mucosal reactive oxygen species production in oesophagitis and Barrett's oesophagus Gut 37, 168-73
5. Hameeteman, W., Tytgat, G. N., Houthoff, H. J., and van den Tweel, J. G. (1989) Barrett's esophagus: development of dysplasia and adenocarcinoma Gastroenterology 96, 1249-56
6. Jankowski, J. A., Wright, N. A., Meltzer, S. J., Triadafilopoulos, G., Geboes, K., Casson, A. G., Kerr, D., and Young, L. S. (1999) Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus Am. J. Pathol. 154, 965-973
7. Heitmiller, R. F., Redmond, M., and Hamilton, S. R. (1996) Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy Ann Surg 224, 66-71
8. Hamilton, S. R. and Smith, R. R. (1987) The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus Am. J. Clin. Pathol. 87, 301-12
9. Montgomery, E., Goldblum, J. R., Greenson, J. K., Haber, M. M., Lamps, L. W., Lauwers, G. Y., Lazenby, A. J., Lewin, D. N., Robert, M. E., Washington, K., Zahurak, M. L., and Hart, J. (2001) Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: A follow-up study based on 138 cases from a diagnostic variability study Human Pathology 32, 379-388
10. Reid, B. J., Levine, D. S., Longton, G., Blount, P. L., and Rabinovitch, P. S. (2000) Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets Am. J. Gastroenterol. 95, 1669-76
11. Kariv, R., Plesec, T. P., Goldblum, J. R., Bronner, M., Oldenburgh, M., Rice, T. W., and Falk, G. W. (2009) The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol Clin. Gastroenterol. Hepatol. 7, 653-8 quiz 606
12. Goldblum, J. R. (2003) Barrett's esophagus and Barrett's-related dysplasia Mod. Pathol. 16, 316-24
13. Kelloff, G. J., Krohn, K. A., Larson, S. M., Weissleder, R., Mankoff, D. A., Hoffman, J. M., Link, J. M., Guyton, K. Z., Eckelman, W. C., Scher, H. I., O'Shaughnessy, J., Cheson, B. D., Sigman, C. C., Tatum, J. L., Mills, G. Q., Sullivan, D. C., and Woodcock, J. (2005) The progress and promise of molecular imaging probes in oncologic drug development Clin. Cancer Res. 11, 7967-7985
14. Hsiung, P. L., Hardy, J., Friedland, S., Soetikno, R., Du, C. B., Wu, A. P., Sahbaie, P., Crawford, J. M., Lowe, A. W., Contag, C. H., and Wang, T. D. (2008) Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy Nat. Med. 14, 454-8
15. Li, M., Anastassiades, C. P., Joshi, B., Kormack, C. M., Piraka, C., Elmunzer, B. J., Turgeon, D. K., Johnson, T. D., Appelman, H., Beer, D. G., and Wang, T. D. (2010) Affinity peptide for targeted detection of dysplasia in Barrett's esophagus Gastroenterology 139, 1472-1480
16. Miller, S. J., Joshi, B. P., Feng, Y., Gaustad, A., Fearon, E. R., and Wang, T. D. (2011) In vivo fluorescence-based endoscopic detection of colon dysplasia in the mouse using a novel peptide probe PLoS One 6, e17384
17. Bird-Lieberman, E. L., Neves, A. A., Lao-Sirieix, P., O'Donovan, M., Novelli, M., Lovat, L. B., Eng, W. S., Mahal, L. K., Brindle, K. M., and Fitzgerald, R. C. (2012) Molecualr imaging using fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett's esophagus Nat. Med. 18, 315-321
18. Murcia, M. J. and Naumann, C. A. (2005) Biofunctionalization of fluorescent nanoparticles, in Nanotechnologies for the life sciences (Kumar, C., Ed.) Wiley-VCH Verlag GmbH, Weinheim.
19. Hahn, M. A., Singh, A. K., Sharma, P., Brown, S. C., and Moudgil, B. M. (2011) Nanoparticles as contrast agents for in-vivo bioimaging: current status and future perspectives Anal. Bioanal. Chem. 399, 3-27
20. Khan, J. A., Kudgus, R. A., Szabolcs, A., Dutta, S., Wang, E., Cao, S., Curran, G. L., Shah, V., Curley, S., Mukhopadhyay, D., Robertson, J. D., Bhattacharya, R., and Mukherjee, P. (2011) Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo PLoS One 6, e20347
21. El-Sayed, I. H., Huang, X., and El-Sayed, M. A. (2005) Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer Nano Lett. 5, 829-34
22. Diagaradjane, P., Orenstein-Cardona, J. M., Colon-Casasnovas, N. E., Deorukhkar, A., Shentu, S., Kuno, N., Schwartz, D. L., Gelovani, J. G., and Krishnan, S. (2008) Imaging epidermal growth factor receptor expression in vivo: Pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe Clin. Cancer Res. 14, 731-741
23. Yang, L. L., Mao, H., Wang, Y. A., Cao, Z. H., Peng, X. H., Wang, X. X., Duan, H. W., Ni, C. C., Yuan, Q. G., Adams, G., Smith, M. Q., Wood, W. C., Gao, X. H., and Nie, S. M. (2009) Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging Small 5, 235-243
24. Acharya, S., Dilnawaz, F., and Sahoo, S. K. (2009) Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy Biomaterials 30, 5737-50
25. Glazer, E. S. and Curley, S. A. (2010) Radiofrequency field-induced thermal cytotoxicity in cancer cells treated with fluorescent nanoparticles Cancer 116, 3285-3293
26. Lee, H., Fonge, H., Hoang, B., Reilly, R. M., and Allen, C. (2010) The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles Mol. Pharm. 7, 1195-208
27. Yang, J., Lim, E. K., Lee, H. J., Park, J., Lee, S. C., Lee, K., Yoon, H. G., Suh, J. S., Huh, Y. M., and Haam, S. (2008) Fluorescent magnetic nanohybrids as multimodal imaging agents for human epithelial cancer detection Biomaterials 29, 2548-55
28. Cronin, J., McAdam, E., Danikas, A., Tselepis, C., Griffiths, P., Baxter, J., Thomas, L., Manson, J., and Jenkins, G. (2011) Epidermal growth factor receptor (EGFR) is overexpressed in high-grade dysplasia and adenocarcinoma of the esophagus and may represent a biomarker of hisotlogical progression in Barrett's esophagus (BE) Am. J. Gastroenterol. 106, 46-56
29. Masui, H., Castro, L., and Mendelsohn, J. (1993) Consumption of EGF by A431 cells: evidence for receptor recycling J. Cell Biol. 120, 85-93
30. Raben, D., Helfrich, B., Chan, D. C., Ciardiello, F., Zhao, L., Franklin, W., Baron, A. E., Zeng, C., Johnson, T. K., and Bunn, P. A., Jr. (2005) The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer Clin. Cancer Res. 11, 795-805
31. Kummer, U. (1986) Tritium radiolabeling of antibodies to high specific activity with N-succinimidyl [2,3-3H]propionate: use in detecting and analyzing monoclonal antibodies Methods Enzymol. 121, 670-8
32. Tang, Y. S., Davis, A.-M., and Kitcher, J. P. (1983) N-succinimidyl propionate: Characterisation and optimum conditions for use as a tritium labelling reagent for proteins J. Labelled Compd. Radiopharm. 20, 277-284
33. Gordon, K. M., Duckett, L., Daul, B., and Petrie, H. T. (2003) A simple method for detecting up to five immunofluorescent parameters together with DNA staining for cell cycle or viability on a benchtop flow cytometer J. Immunol. Methods 275, 113-21
34. Popielarski, S. R., Pun, S. H., and Davis, M. E. (2005) A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 1. Synthesis and characterization Bioconjugate Chem. 16, 1063-70
35. Lee, J., Choi, Y., Kim, K., Hong, S., Park, H.-Y., Lee, T., Park, G. J., and Song, R. (2010) Characterization and cancer cell specific binding properties of anti-EGFR antibody conjugated quantum dots Bioconjugate Chem. 21, 940-946
36. Gref, R., Luck, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S., Blunk, T., and Muller, R. H. (2000) 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption Colloids Surf., B: Biointerfaces 18, 301-313
37. Chen, S. F., Liu, L. Y., Zhou, J., and Jiang, S. Y. (2003) Controlling antibody orientation on charged self-assembled monolayers Langmuir 19, 2859-2864
38. Lin, J. J., Silas, J. A., Bermudez, H., Milam, V. T., Bates, F. S., and Hammer, D. A. (2004) The effect of polymer chain length and surface density on the adhesiveness of functionalized polymersomes Langmuir 20, 5493-5500
39. Jokerst, J. V., Lobovkina, T., Zare, R. N., and Gambhir, S. S. (2011) Nanoparticle PEGylation for imaging and therapy Nanomedicine (Lond.) 6, 715-28
40. Ma, L. L., Tam, J. O., Willsey, B. W., Rigdon, D., Ramesh, R., Sokolov, K., and Johnston, K. P. (2011) Selective targeting of antibody conjugated multifunctional nanoclusters (nanoroses) to epidermal growth factor receptors in cancer cells Langmuir 27, 7681-7690
41. van Erp, R., Linders, Y. E., van Sommeren, A. P., and Gribnau, T. C. (1992) Characterization of monoclonal antibodies physically adsorbed onto polystyrene latex particles J. Immunol. Methods 152, 191-9
42. Wood, W. G. and Gadow, A. (1983) Immobilisation of antibodies and antigens on macro solid phases - a comparison between adsorptive and covalent binding. A critical study of macro solid phases for use in immunoassay systems. Part I J. Clin. Chem. Clin. Biochem. 21, 789-97
43. Wang, W., Xiong, W., Wan, J., Sun, X., Xu, H., and Yang, X. (2009) The decrease of PAMAM dendrimer-induced cytotoxicity by PEGylation via attenuation of oxidative stress Nanotechnology 20, 105103
44. Fant, K., Esbjorner, E. K., Jenkins, A., Grossel, M. C., Lincoln, P., and Norden, B. (2010) Effects of PEGylation and Acetylation of PAMAM Dendrimers on DNA Binding, Cytotoxicity and in Vitro Transfection Efficiency Mol. Pharmaceutics 7, 1734-46
45. Li, Y., Wo, J. M., Ray, M. B., Jones, W., Su, R. R., Ellis, S., and Martin, R. C. (2006) Cyclooxygenase-2 and epithelial growth factor receptor up-regulation during progression of Barrett's esophagus to adenocarcinoma World J. Gastroenterol. 12, 928-34
46. Boiko, I. V., Mitchell, M. F., Hu, W., Pandey, D. K., Mathevet, P., Malpica, A., and Hittelman, W. N. (1998) Epidermal growth factor receptor expression in cervical intraepithelial neoplasia and its modulation during an alpha-difluoromethylornithine chemoprevention trial Clin. Cancer Res. 4, 1383-91